Bleomycin sclerotherapy may be an effective therapy for lymphangiomas: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-03-19 11:45 GMT | Update On 2021-03-19 11:45 GMT

Saudi Arabia: Bleomycin sclerotherapy could be an effective treatment for lymphangiomas, finds a recent study in the journal Dermatologic Surgery. According to the study, the procedure is associated with fewer complications, however, about a quarter of patients experienced recurrence.

Bleomycin sclerotherapy is a popular nonsurgical option for lymphangiomas management. However, the efficacy of the procedure is not thoroughly evaluated. Osama Bawazir, Faculty of Medicine in Umm Al-Qura University at Makkah, Makkah, Saudi Arabia, and colleagues, therefore, aimed to assess the clinical outcomes and the effectiveness of bleomycin injection for the treatment of lymphangioma.

For the purpose, the researchers conducted a retrospective study across 4 centers. It included 47 infants and children having bleomycin sclerotherapy between November 2005 and September 2020.

Men presented 53.2% of the study sample (n = 25), and the most common site was the head and neck (n = 29, 61.7%).

Key findings of the study include:

Two injections were required in 11 patients (23.4%), and 7 patients (14.9%) required 3 or more injections.
Excellent response was achieved in 63.8% (n = 30), 14 patients (29.8%) had a good response, and 4 had a poor response (8.5%).
There was no difference in the response according to the site of the lesion.
The most frequent complication was recurrence (n = 11, 23.4%), and swelling occurred in 5 patients (10.6%).
No patient had facial or phrenic nerve palsy or hoarseness.
Two patients had persistent pain, and 2 had an infection (4.3%).

"Intralesional bleomycin injection could be an effective therapy for lymphangiomas," wrote the authors. "The procedure has a low complication profile, and long-term study is recommended to evaluate the systemic and late bleomycin injection complications."

Reference:

The study titled, "Efficacy and Clinical Outcomes of Bleomycin in the Treatment of Lymphangiomas: A Multicenter Experience," is published in the journal Dermatologic Surgery.

DOI: https://journals.lww.com/dermatologicsurgery/Abstract/9000/Efficacy_and_Clinical_Outcomes_of_Bleomycin_in_the.97584.aspx

Article Source : Dermatologic Surgery

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Bleomycin sclerotherapy may be an effective therapy for lymphangiomas: Study

Similar News

Botanical-Based Hydrogel Promising in Treating Diabetic Foot Ulcers, Finds New Study

Global Study Finds Nearly 1 Percent of Population Affected by Hidradenitis Suppurativa

Elevated serum vitamin D levels are linked with higher skin cancer risk, finds study

Alopecia Areata Linked to Autoimmune Thyroid Diseases, Suggests Study

Infection Risk among HS Patients Compared to Psoriasis: JAMA

Roflumilast Cream 0.3% Safe and Effective for Plaque Psoriasis in Children Aged 2-11 Years: Study

Study Finds No Clear Link Between Vitiligo and Cancer Risk

Novel dietary Supplement AGA-P Enhances Effectiveness of Parmacological Treatments for Androgenic Alopecia: Study